Area of research
Genetics · Molecular Biology
Research interest
Research focused on Cancer research and Prostate cancer, with related work in Apoptosis, Deubiquitinating enzyme, Bevacizumab. Notable publications include 'USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc', 'Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients', and 'KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells'.
Discovery of Novel Oxazolo[4,3-<i>f</i>]purine Derivatives as Antitumor Agents through PPIA Interaction
Design, synthesis, and antitumor activity of novel thioheterocyclic nucleoside derivatives by suppressing the c-MYC pathway
USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
Bifunctional chiral selenium-containing 1,4-diarylazetidin-2-ones with potent antitumor activities by disrupting tubulin polymerization and inducing reactive oxygen species production
17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation
KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells
Up-Regulation of c-Fos Associated with Neuronal Apoptosis Following Intracerebral Hemorrhage
Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients